SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCalculus Vct Regulatory News (CLC)

Share Price Information for Calculus Vct (CLC)

Share Price is delayed by 15 minutes
Get Live Data
53.25    0.00 (0.00%)
Bid:
48.00
Ask:
58.50
Spread: 10.50 (21.875%)
Market Cap: £51.93m
CLC Live PriceLast checked at - London Stock Exchange

Intraday Calculus Vct Share Chart

Issue of Equity

31 Jan 2017 12:12

RNS Number : 6161V
Calculus VCT PLC
31 January 2017
Β 

Calculus VCT plc

31 January 2017

Offer and Issue of Equity

The Board of Calculus VCT plc is pleased to announce that, in connection with the offer for subscription for D ordinary shares of 1p each ("D Shares") that opened on 25 November 2016 ("Offer"), an allotment of 3,084,573 D Shares in respect of the 2016/2017 tax year has taken place today at an average issue price of 96.49p per share. Application for the D Shares to be admitted to the Official List of the UK Listing Authority and to trading on the London Stock Exchange's main market for listed securities has been made and it is expected that admission will take place on 2 February 2017.

Applications in respect of the 2016/2017 tax year may continue be lodged until 5.00 p.m. on 3 April 2016, unless the offer is closed earlier, by delivery to the offices of the receiving agent, The City Partnership (UK) Limited, 110 George Street, Edinburgh EH2 4LH.

Following this allotment, the issued share capital and total voting rights of the Company comprises:

Β 

Number of shares in issue

Voting rights

Votes per share

Ordinary shares of 1p each

4,738,463

4,738,463

1

C shares of 1p each

1,931,095

1,931,095

1

D shares of 1p each

6,898,128

6,898,128

1

Total voting rights

13,567,686

13,567,686

1

Β 

The above total number of voting rights should be used by shareholders as the denominator for calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure and Transparency Rules.

Included in the above allotment, John Glencross, a director of the Company, subscribed for 10,491 new ordinary shares at 95.32p per share (a subscription of Β£10,000). This transaction falls as a smaller related party transaction within the definition of Listing Rule 11.1.10R because this dealing, when aggregated with a subscription by Mr Glencross for 9,700 shares on 9 March 2016, exceeds the 0.25% de minimis threshold as set out in LR11.1.10R.

Mr Glencross's shares were acquired on the same terms as, and on no more favourable a basis than, those shares subscribed for by other investors in this allotment.

SPARK Advisory Partners Limited, the Company's sponsor, has provided written confirmation that the terms of the agreement are fair and reasonable so far as the shareholders of the Company are concerned.

Following this transaction Mr Glencross has 20,191 D shares, amounting to 0.29 per cent of the D shares in issue, and 25,000 Ordinary shares, together amounting to 0.33 per cent of the total shares in issue, in each case as enlarged by today's allotment.

Β 

Calculus Capital Limited

Company Secretary

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
IOEMMGFMZMMGNZM
Date   Source Headline
22nd Apr 20263:39 pmRNSTransaction in Own Shares
31st Mar 20265:55 pmRNSDirectorate change
25th Mar 20262:23 pmRNSIssue of Equity
18th Feb 20263:14 pmRNSIssue of Equity
22nd Jan 20269:29 amRNSTransaction in Own Shares
16th Jan 20264:34 pmRNSNet Asset Value(s)
14th Jan 20263:00 pmRNSDividend Declaration
18th Dec 20252:30 pmRNSIssue of Equity
18th Dec 20252:30 pmRNSIssue of Equity
17th Dec 20253:15 pmRNSIssue of Equity
15th Dec 20253:10 pmRNSHalf-year Financial Report
14th Oct 20254:33 pmRNSTransaction in Own Shares
3rd Oct 202511:42 amRNSPublication of a Prospectus
2nd Oct 20254:29 pmRNSIssue of Equity
24th Sep 202511:22 amRNSResult of AGM & Change in Directorship
2nd Sep 20252:48 pmRNSIssue of Equity
28th Aug 202512:38 pmRNSPublication of Supplementary Prospectus
27th Aug 20252:52 pmRNSNet Asset Value
31st Jul 20259:46 amRNSAnnual Report with updated dividend details
30th Jul 202511:31 amRNSAnnual Financial Report &Related Party Transaction
3rd Jul 20259:17 amRNSIssue of Equity
10th Jun 20254:41 pmRNSTransaction in Own Shares
5th Jun 20254:39 pmRNSTransaction in Own Shares
4th Apr 20255:15 pmRNSIssue of Equity
26th Mar 20253:21 pmRNSIssue of Equity
11th Mar 20255:11 pmRNSChange of auditor
20th Feb 20254:30 pmRNSIssue of Equity
12th Feb 20254:39 pmRNSTransaction in Own Shares
21st Jan 20255:11 pmRNSNet Asset Value(s)
10th Jan 20253:46 pmRNSIssue of Equity update
18th Dec 20244:24 pmRNSIssue of Equity - 18 December 2024
5th Dec 20245:25 pmRNSHalf-year Report
14th Oct 20241:40 pmRNSPublication of a Prospectus
8th Oct 20245:23 pmRNSTransaction in Own Shares
9th Sep 202411:48 amRNSStatement re Intention to Fund Raise
29th Aug 20245:32 pmRNSIssue of Equity
22nd Aug 20244:27 pmRNSResults of Annual General Meeting
31st Jul 20245:44 pmRNSIssue of Equity
17th Jul 20241:51 pmRNSNet Asset Value(s)
11th Jul 20245:38 pmRNSAnnual Financial Report
24th Apr 20244:49 pmRNSTransaction in Own Shares
5th Apr 20242:54 pmRNSIssue of Equity - 5 April 2024
22nd Feb 20244:38 pmRNSDirectorship Change
15th Feb 202411:53 amRNSIssue of Equity - 15 February 2024
1st Feb 20244:38 pmRNSNet Asset Value - 31 December 2023
10th Jan 20245:27 pmRNSTransaction in Own Shares
21st Dec 202310:08 amRNSDirectorate Change
15th Dec 20233:25 pmRNSIssue of Equity - 15 December 2023
20th Nov 20232:11 pmRNSSeptember 2023 NAV Announcement
13th Nov 20234:46 pmRNSHalf-year Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.